Lanraplenib
Lanraplenib Uses, Dosage, Side Effects, Food Interaction and all others data.
Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
| Trade Name | Lanraplenib |
| Generic | Lanraplenib |
| Lanraplenib Other Names | Lanraplenib |
| Type | |
| Formula | C23H25N9O |
| Weight | Average: 443.515 Monoisotopic: 443.218206461 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lanraplenib
